Takeda Pharmaceutical
Satish C. Rao, MD, MS, currently serves as the Head of Orexin and Senior Director at Takeda, overseeing multi-asset orexin programs and leading the US medical strategy from phase 1 to phase 4. Previously, Satish held several leadership roles within Takeda, including Director for Developmental & Epileptic Encephalopathies and Medical Director for Developmental Epilepsy, where responsibilities encompassed medical strategy, life cycle management, and scientific oversight. Satish has a rich background in neurology, having served as Medical Director of the EEG Laboratory at Boulder Community Health and as Medical Director of Neuroscience at Floyd Memorial Hospital. Additionally, Satish was the CEO and co-founder of Olivecell, a digital biomarker company, and worked as an Assistant Professor at the University of Louisville. Educational achievements include a Doctor of Medicine and Master's degree in Neuroscience from the University of Louisville, complemented by a Bachelor of Arts in Biology.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
177 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.